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Background: Routine services for tuberculosis (TB) are being disrupted by stringent lockdowns against the
novel SARS-CoV-2 virus. We sought to estimate the potential long-term epidemiological impact of such dis-
ruptions on TB burden in high-burden countries, and how this negative impact could be mitigated.
Methods: We adapted mathematical models of TB transmission in three high-burden countries (India, Kenya
and Ukraine) to incorporate lockdown-associated disruptions in the TB care cascade. The anticipated level of
disruption reflected consensus from a rapid expert consultation. We modelled the impact of these disrup-
tions on TB incidence and mortality over the next five years, and also considered potential interventions to
curtail this impact.
Findings: Even temporary disruptions can cause long-term increases in TB incidence and mortality. If lock-
down-related disruptions cause a temporary 50% reduction in TB transmission, we estimated that a 3-month
suspension of TB services, followed by 10 months to restore to normal, would cause, over the next 5 years,
an additional 119 million TB cases (Crl 106133) and 361,000 TB deaths (CrI 333394 thousand) in India,
24,700 (16,10044,700) TB cases and 12,500 deaths (8.817.8 thousand) in Kenya, and 4,350 (8266,540)
cases and 1,340 deaths (8151,980) in Ukraine. The principal driver of these adverse impacts is the accumu-
lation of undetected TB during a lockdown. We demonstrate how long term increases in TB burden could be
averted in the short term through supplementary “catch-up” TB case detection and treatment, once restric-
tions are eased.
Interpretation: Lockdown-related disruptions can cause long-lasting increases in TB burden, but these nega-
tive effects can be mitigated with rapid restoration of TB services, and targeted interventions that are imple-
mented as soon as restrictions are lifted.
Funding: USAID and Stop TB Partnership
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The emergence of the novel virus SARS-CoV-2 has caused morbid-
ity, mortality and societal disruption on a global scale. In the absence
of pharmaceutical interventions, many countries have resorted to
population-wide lockdowns to slow the spread of the virus and to
allow their health systems to cope [1]. These lockdowns have had animportant effect on SARS-CoV-2 transmission [2,3]. However, unin-
tended consequences are inevitable with such sweeping measures. In
low- and middle-income countries with health systems already
under strain, the adverse effects of disruptions in health services (for
example, ongoing transmission of infectious diseases) can last far
beyond the period of the disruptions themselves [46].
In the present study we focus on tuberculosis (TB) - globally, the
leading cause of death due to an infectious disease [7]. In recent deca-
des TB incidence and mortality have been steadily declining, reflect-
ing ongoing improvements in diagnosis, treatment and prevention
[8]. However, in March 2020 a rapid analysis conducted by the Stop
Research in context
Evidence before this study
We searched both the published and grey literature for relevant
studies in this context, using the terms “(SARS-CoV-2 OR coro-
navirus OR COVID-19) AND Tuberculosis,” limited to publica-
tions in English. One modelling study found it unlikely that TB
transmission reductions could compensate for the adverse
impacts of disrupted TB services. Another study used
approaches relating notifications to TB mortality, to estimate
the excess TB deaths that could occur globally, under different
lockdown scenarios. We found no studies examining the poten-
tial impact of disruptions at different stages of the TB care cas-
cade, nor for post-lockdown strategies for reconstituting TB
services.
Added value of this study
We focused on India, Kenya and Ukraine, three high-burden
countries, representing contrasting epidemiological conditions.
In each country we modelled the impact of a range of lockdown
scenarios, informed by expert consensus on the potential
effects of a lockdown at various points in the TB care cascade.
For each country we additionally examined which type of dis-
ruption (i.e. acting at which point on the care cascade) would
be most associated with excess TB burden. Using insights from
this analysis, we identified potential strategies for high-burden
countries to bring their TB responses back on track.
Implications of all the available evidence
Even short-term disruptions can trigger escalations in TB bur-
den that can take years to return to pre-lockdown levels. Such
increases can be explained by an accumulating pool of unde-
tected, untreated TB during a lockdown. Accordingly, country
preparedness should involve ‘catch-up’ plans to intensify
screening, evaluation and treatment of ‘missed’ cases of TB,
immediately upon lifting a lockdown.
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lockdowns on TB care in different countries [9]. For example, in the
weeks following the imposition of a nationwide lockdown on March
24, 2020, India reported an 80% drop in daily notifications of TB [9]
relative to average pre-lockdown levels. Similar changes have been
reported elsewhere, for example with South Africa reporting a drop
in numbers tested for TB by almost a half [10]. Such declines may be
partly due to delays in reporting but are also likely to reflect reduc-
tions in access to diagnosis and treatment, potentially having a last-
ing impact on TB burden at a country-wide level. Missed diagnoses
would mean increased opportunities for transmission, while wors-
ened treatment outcomes increase the risk of death from TB. There-
fore, while lockdowns are an important measure to mitigate the
immediate impact of COVID-19, it is critical to anticipate (i) the
potential long-term impact of these measures on TB and other dis-
eases, and (ii) how this impact might be stemmed, in the short term,
by appropriately targeted investment and effort. We therefore aimed
to examine these questions using mathematical modelling of TB
transmission dynamics. Building on earlier modelling conducted for
the 2019 Lancet Commission on Tuberculosis [11,12], we modelled
the potential TB-related impact of COVID-related lockdowns - and
mitigating effects of potential post-lockdown interventions - in three
focal countries: India, the Republic of Kenya, and Ukraine. It is not
possible to predict the extent or depth of lockdowns in any given
country, let alone their impact on TB services. Therefore, the primary
purpose of our analysis is not to predict future TB trajectories, butrather to identify the critical drivers through which a lockdown can
lead to elevated TB incidence and mortality, and to apply these
insights to understand how best mitigate the long-term adverse
impact of any lockdown-related disruptions.
Methods
Model overview
For each country we drew from previously published models of M.
tuberculosis transmission [12], which were designed to capture
essential features of the TB care cascade. For the current analysis, this
approach allowed us to model the impact of disruptions acting at
multiple points in the care cascade. The three country settings offer
examples of contrasting types of TB care cascade: for India we incor-
porated the dominant role of the private healthcare sector in provid-
ing TB care;[13] for Kenya, the role of HIV in driving TB dynamics;
[14] and for Ukraine, the burden of drug resistance [15]. The overall
model structure is illustrated schematically in Fig. S1 in the appendix.
As noted above, the purpose of the analysis was not to predict TB tra-
jectories in these three countries, but rather to examine the impor-
tance of different types of disruptions (i.e. acting at different stages of
the TB care cascade), thus providing insights that could be relevant to
other high-burden countries sharing similar characteristics. We cali-
brated each country model to the available data on TB burden, includ-
ing WHO estimates of TB incidence and mortality [7], and on the
burden of drug resistance (see Table S1). Full details of each model
are provided in the Supporting Information.
Calibration was performed using Markov Chain Monte Carlo
(MCMC) simulation [1618], whereby we allowed model parameters
to vary over pre-specified prior distributions, using a likelihood func-
tion based on the calibration targets listed above to weight simulations
according to their fit to the observed data. For each country, we drew
250 samples from the weighted (posterior) density of simulations fol-
lowing burn-in and thinning as described in the Supporting Informa-
tion. We then performed model projections on the basis of each of
these samples, under the lockdown scenarios described below. For any
model projection (for example, incidence over time), we estimated
Bayesian credible intervals as 25th and 975th percentiles, and central
estimates as 50th percentiles, of the corresponding posterior density.
Modelling the impact of disruptions
Disruptions to TB services can act at all stages of the TB care cas-
cade. During a lockdown, movement restrictions would curtail oppor-
tunities for those experiencing TB symptoms to seek care. Even once
these people are able to visit a provider or health facility, the diagnos-
tic and laboratory capacity needed to support TB diagnosis may be
severely reduced for example, with molecular diagnostic tools for TB
being repurposed for COVID-19 [19] or TB laboratory staff being redir-
ected to Covid-19 efforts. National TB programmes are investing signif-
icant effort to continue supporting those already on TB treatment, but
there are also concerns that lockdown conditions may interfere with
the continued supply of drugs [20]. To capture this range of possible
disruptions, we performed a rapid consultation amongst experts at the
Stop TB Partnership and the United States Agency for International
Development (USAID). Table 1 lists those experts’ consensus opinion
as to the degree to which TB services could be disrupted by COVID-
related lockdowns, at each step of the care cascade. There is substantial
uncertainty around these possible impacts, and as described below, a
key part of this analysis is to resolve the specific disruptions that
would have the greatest influence on long-term TB burden.
Depending on its readiness, a country TB programme may take
weeks or months to restore TB services to normal after a lockdown.
This process may be delayed if, for example, laboratory capacity for
diagnosis needs time to be reconstituted for TB, or indeed if there
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as a consequence of fear and stigma caused by the COVID-19 pan-
demic. Accordingly, to model the impact of the lockdown and its
aftermath, we assumed two phases: a ‘suspension’ period of given
duration, during which all impacts listed in Table 1 are in full effect,
followed by a ‘restoration’ period, during which TB services are grad-
ually (for simplicity, linearly) restored to normal. The suspension
period is expected to last for as long as the lockdown is in effect, and
potentially for longer: even once restrictions are eased, it may take
some time for the reconstitution of TB services to begin, and for nor-
mal careseeking to begin resuming. We also assumed that TB trans-
mission would revert to normal at the end of the suspension period,
as a result of contact rates in the community rapidly being restored
to normal. This assumption may be appropriate in high-burden, low-
income settings where physical distancing is less feasible than in
high-income settings, but also where there are strong economic
incentives to restore livelihoods as soon as possible. We present
results for two disruption scenarios: a ‘mild’ scenario consisting of a
2-month suspension followed by a 2-month restoration period for TB
services, and a ‘severe’ scenario consisting of a 3-month suspension
followed by a 10-month restoration period.
In each scenario we simulated the excess TB cases and deaths that
would arise, over the period from 20202025, compared against a
situation where TB services continue as normal over this period. In
doing so, we ignore potential expansions in TB care in our compara-
tor scenario, for example the scale-up of engagement with the private
sector in India that was ongoing prior to the COVID-19 pandemic
[21]. Our analysis therefore does not include the foregone benefits
from continuing these expansions, and so we expect our model pro-
jections to be conservative with respect to the excess TB burden aris-
ing from the lockdown.Table 1
Expert consensus on potential disruptions arising from COVID-related lockdowns in th
Indicator Reason for effect India
From initiation of lockdown1
Reduction in transmission (DS-
and DR-TB)
Physical distancing Drops by 50%2
Initial (pre-care seeking) patient
delay3
Restriction on movements Increase by 50%
Probability of diagnosis per
attempted clinic visit
Reduced lab capacity and avail-
ability of healthcare staff
Drops by 70%
First-line treatment completion,
public sector and any engaged
private sector
Healthcare staff unable to moni-
tor and support treatment as
usual
Drops to 70%, f
Second-line treatment comple-
tion, public sector and any
engaged private sector
Drops to 25%, f
Starting one month into lockdown1
Proportion of TB diagnoses hav-
ing DST result
Xpert machines and other lab
facilities used for COVID-19
response
Drops to 5%from
Treatment initiation Stockouts and supply
interruptions
Drops to 25% fr
Proportion of PLHIV receiving
IPT
Disruptions in HIV care 4
Footnotes: Scenarios were constructed through a rapid consultation with experts in th
vey of national TB programmes 9. The scenarios listed here are not predictive, but illu
potential impact of different types of disruption.
Footnotes:
Abbreviations: COVID-19: coronavirus disease 2019, DR: drug-resistant (i.e. rifampicin-
nodeficiency virus, IPT: isoniazid preventive therapy, PLHIV: people living with HIV, TB
1 For the initial levels and uncertainty intervals of these parameters in each country
2 Lockdowns would have the effect of reducing transmission in the community lev
models do not incorporate household vs community structure, these scenarios instead
In urban slums in particular, where TB transmission is strongest, overcrowding may te
in the supporting information, we present corresponding sensitivity analyses to these a
3 The initial patient delay is an assumed interval of active, infectious TB, prior to a
(see Table S1 for data, and Tables S2S5 for parameter estimates).
4 For simplicity, only the Kenya model incorporates the role of HIV/TB coinfection
Ukraine has a high burden of HIV as well; in the present study, our focus in Ukraine is oWe also extrapolated estimates from our three focal countries to
the global level using a simple approach, detailed in the supporting
information (section 3). We used the India model to inform projec-
tions for countries with high TB burden and private sector involve-
ment; the Kenya model to inform projections for countries where
HIV is a driver of the TB epidemic; and the Ukraine model to inform
projections for countries with a high proportion of drug-resistant TB,
and hospital-based care delivery systems. Countries not in these
groups were assigned the average impact of the three country mod-
els; we then aggregated country-level results to the global level.
Sensitivity analysis
We conducted a ‘leave-one-out’ analysis, in which we simulated the
impact of the lockdown, but in the absence of a single element in Table 1
(for example, a scenario where all impacts are in full effect with the
exception of diagnosis, which remains at pre-lockdown levels). This
analysis allows an assessment of how excess TB burden may vary under
more limited disruptions than the full set of scenarios identified in
Table 1. In doing so, this analysis also helps to identify which types of
disruption have the strongest contribution to excess TB burden. By per-
forming a ‘leave-one-out’ simulation for each row of Table 1 in turn, we
aimed to estimate the influence of each type of disruption.
Additionally, while many of the assumptions in Table 1 can be
refined as further data become available, the effect of reduced contact
rates in particular will be challenging to measure empirically. Recent
analysis has examined the potential impact of different levels of
transmission reduction [22], finding, for example, that these are
unlikely to counterbalance the effects of disruptions in TB services.
Our current analysis complements this work by capturing details of
TB services. As discussed below, there is wide uncertainty aroundree countries.
Kenya Ukraine
Drops by 50%2 Drops by 50%2
Increase by 50% Increase by 30%
Drops by 70% Drops by 50%
rom 90%1 Drops to 70%, from 89% (HIV -ve)
and 82% (HIV +ve) 1
Drops to 50%, from 74% 1
rom 51% 1 Drops to 25%, from 72% 1 Drops to 25%, from 49% 1
30% 1 Drops to 5% from 46% 1 Drops to 25%, from 74% (new)
and 47% (retreatment) 1
om 88% 1 Drops to 25% from 80% 1 Drops to 50%, from 93% 1
Drops to 10% 4
e Stop TB Partnership and USAID, the former using information from a rapid sur-
strative on the basis of current information: they offer a basis for examining the
resistant), DS: drug-susceptible, DST: drug susceptibility test, HIV: human immu-
: tuberculosis.
, see Tables S2S5 (entries highlighted in yellow) in the supporting information.
el, but also intensifying and prolonging exposure at the household level. As our
aim to capture the net effect of changes in household vs community transmission.
nd to reduce the effect of any lockdown on community transmission. In section 3
ssumptions.
patient’s first presentation for care. It is calibrated to match epidemiological data
, which is estimated to account for 27% of incident TB. However, we note that
n the role of drug-resistant TB.
4 L. Cilloni et al. / EClinicalMedicine 28 (2020) 100603potential TB transmission reductions during a lockdown. There is evi-
dence for contact rates being reduced by lockdown, even in informal
settlements in Kenya [23], and masque use may further decrease
transmission [24]. However, it is not yet known how strong these
transmission-reducing effects might be for TB, for example when
weighed against the potential for prolonged and intensified exposure
within the household. We therefore adopted a central estimate of
50% (see Table 1), while also adopting a wide range of scenarios from
10% to 75%. Under each scenario we calculated the excess cases and
deaths that would occur between 2020 and 2025.
Role of the funding source
SAM, AM, EM and SS are employed by the Stop TB Partnership,
and SA is employed by USAID. The funders of the study otherwise
had no role in study design, data collection, data analysis, data inter-
pretation, or writing of the manuscript. The corresponding author
had full access to all the data in the study and had final responsibility
for the decision to submit for publication. All authors approved the
final version of the manuscript submitted for publication.
Results
Figures S2  S4, and Tables S2  S5 in the supporting information,
show the model calibrations to each of the targets shown in Table 1.
On the basis of these calibrations, following a mild disruption we pro-
jected that between 2020 and 2025, in India there would be an
increase of 182,000 TB cases (95% Bayesian credible interval (CrI)
159211 thousand) and 83,600 TB deaths (95% CrI 77.590.6Fig. 1. The potential impact of a lockdown on TB incidence in India, Kenya and Ukraine. Sho
narios: (i) a ‘mild’ scenario with a 2-month lockdown and a 2-month restoration (orange), a
Bars labelled with 'S' and 'R' denote, respectively, the suspension and restoration periods, wi
we assume that the disruptions in Table 1 are in full effect during the suspension period, and
vals show 95% Bayesian credible intervals, reflecting uncertainty in pre-lockdownmodel parathousand). Likewise, in Kenya there would be an additional 489 cases
(95% CrI 26005700) and 2460 deaths (95% CrI 1600  3800), and
in Ukraine an additional 840 cases (95% CrI 460  1500) and 330
deaths (95% CrI 153 - 570) (see Figs. 1 and 2, andTable 2). Although
these results suggest the possibility of a net reduction in TB incidence
in Kenya and Ukraine (as a result of the assumed 50% reduction in
transmission during the lockdown), such reductions only manifest
under this mild scenario: in the case of a severe disruption, results
suggest that TB incidence could increase by 39% between 2020 and
2025, and that TB deaths could increase by 416% in this same
period.
In terms of the monthly dynamics, Figs. 1 and 2 illustrate that
increases in incidence and mortality typically last longer than the
duration of disruption. Indeed, in India, incidence was projected to
remain at least 4% higher than a “business-as-usual” baseline for a
period of 32 months, even in the mild scenario of a two-month sus-
pension followed by two-month restoration (Fig. S5).
In India, the three specific service disruptions having the most
effect on incidence and mortality are, in order: the increase in the ini-
tial patient delay before first presenting to a provider; the probability
of diagnosis per visit to a provider; and the drop in treatment initia-
tion (Fig. 3: leaving aside transmission, which we address below).
Likewise in Kenya, the same three factors appear as most influential
on the impact of the lockdown, on both TB incidence and mortality.
In Ukraine, a setting with a high burden of drug resistance, the drop
in second-line treatment completion was far more influential on
overall impact, the drop in drug sensitivity testing, and the drop in
the probability of TB diagnosis per visit to a provider were also
important considerations.wn is monthly TB incidence in each country, in 2020 and 2021, for two disruption sce-
nd (ii) a ‘severe’ scenario with a 3-month lockdown and a 10-month restoration (red).
th numbers giving the duration in months in each period. As described in the main text,
that they are reduced to zero in a linear way over the restoration period. Shaded inter-
meters. Cumulative excess TB incidence over the period 20202025 is given in Table 2.
Fig. 2. The potential impact of a lockdown on TB deaths in India, Kenya and Ukraine. As for Fig. 1, but showing monthly TB deaths in each country. As in Fig. 1, bars labelled with 'S'
and 'R' denote, respectively, the lockdown and restoration periods, with numbers giving the duration in months of each period. Shaded intervals show 95% Bayesian credible inter-
vals, reflecting uncertainty in pre-lockdown model parameters. Excess TB deaths over the period 20202025 are listed in Table 2.
Table 2
Excess TB incidence and deaths between 2020 and 2025 as a result of the different scenarios for COVID-related lockdowns.
Country Excess cases between 2020 and 2025 Excess deaths between 2020 and 2025
(% increase) [95% CrI] (% increase) [95% CrI]
2-month suspension + 2-month
restoration
3-month suspension + 10-month
restoration
2-month suspension + 2-month
restoration
3-month suspension + -month
restoration
India 182,000 [159,000211,000] 1190,000 [1060,0001330,000] 83,600 [77,50090,600] 361,000 [333,000394,000]
(1.43% [1.301.65%]) (9.25% [8.5310.40%]) (3.65% [3.483.95%]) (15.70% [1516.80%])
Kenya 489 [26605720] 24,700 [16,10044,700] 2460 [15903840] 12,500 [879017,800]
(0.0076% [0.350.81%]) (3.36% [2.286.11%]) (1.30% [0.862.30%]) (6.58% [5.3010.0%])
Ukraine 835 [4601520] 4350 [8266540] 332 [153570] 1340 [8151980]
(0.60% [0.301.03%]) (2.96%[0.524.47%]) (1.15% [0.551.73%]) (4.64% [2.846.27%])
Abreviations: CrI-credible interval. All estimates are over the period from the beginning (1 Jan) of 2020 to the beginning of 2025. Percentages show increases in cases and
deaths relative to a baseline of no disruption (blue lines in Figs. 1,2).
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ing and treatment initiation, is an expansion of the pool of indi-
viduals with undetected and untreated TB. Fig. 4 shows how the
size of this pool grows over time; the right-hand panel illustrates
the potential impact of a two-month campaign to reduce the
prevalence of untreated TB in India through expanded case find-
ing to reach an monthly notification target of 17 per 100,000
population per month, immediately upon easing of lockdown
restrictions (i.e., implemented alongside the restoration of TB
services). Depending on disruption severity and duration of resto-
ration, such a two-month campaign could, pre-emptively, fully
avert the adverse impact of the lockdown, by bringing 5-year
incidence trends back to pre-lockdown levels. Below we discuss
potential approaches for implementing these post-lockdown
measures.In addition to service disruptions, Fig. 3 illustrates that transmis-
sion reductions are also influential in the excess TB burden caused by
a lockdown. We therefore conducted additional analyses to examine
how model projections are affected by our assumptions for transmis-
sion. Fig. 5 shows estimates for excess incidence and mortality in all
three countries, illustrating overall that, although it is possible for
transmission reductions to give rise to net reductions in cumulative
TB burden, this effect only occurs under the mildest disruption sce-
nario (orange curve), and under the heaviest transmission reduction
scenarios.
Additional analyses, provided in the supporting information (section
3), extrapolates from these three focal countries to the global level. This
approach suggests, for example, that a severe suspension scenario could
lead to an additional 4702,800 TB cases, and an additional 1044,800 TB
deaths worldwide between 2020 and 2025 (Table S6).
Fig. 3. Sensitivity analysis: influence of specific components of a lockdown on excess TB cases and deaths. Shown here is a ‘leave-one-out’ analysis, where we simulate a scenario
with all disruptions in Table 1 in effect, with the exception of one (given by the label to the left). Bars in the figures show the excess TB burden between 2020 and 2025 arising from
this scenario, relative to the scenario where all disruptions are in effect. Vertical lines mark median excess TB cases and deaths in the ‘full-impact’ scenario. The largest bars therefore
indicate those types of disruption that are most influential, for excess TB burden. Left-hand panels show results in terms of excess TB incidence, and right-hand panels show excess
TB deaths. Error bars show 95% credible intervals, calculated by iterating this process over 250 posterior samples for each country. Abbreviations: DST: drug susceptibility test, FL:
first-line, HIV: human immunodeficiency virus, IPT: isoniazid preventive therapy, SL: second-line, Tx: treatment.
Fig. 4. The role of undetected prevalent TB and the impact of short-term supplementary measures to reduce this burden. The left-hand panel shows, in the example of India, the
growth in the prevalence of undetected and untreated TB during the lockdown period, taking the example of a 2-month lockdown followed by a 2-month restoration. As described
in the text, this expanded pool of prevalent TB is a source of short-term increase in TB mortality, as well as seeding new infections of latent TB that manifest as incident TB disease
over the subsequent months and years. The right-hand panel shows the effect of ‘supplementary measures’ that are instigated immediately upon lifting the lockdown, and that
operate over a two-month period to reach these missed cases and initiate them on treatment as rapidly as possible. In practical terms, such efforts could be guided by notification
targets. Shown in the figure is the example of a mild lockdown scenario, followed by supplementary measures that aim to reach a peak target of 14 (95%CrI 1316) monthly notifi-
cations per 100,000 population.
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Fig. 5. Sensitivity analysis to the extent of TB transmission reduction during the suspension period. In other figures we assume that transmission is reduced by 10% (see Table 1),
and here we examine the potential implications of more substantial reductions. Lines show the percent increase in cumulative incidence (upper row) and cumulative TB mortality
(lower row) between 2020 and 2025, compared to a baseline of TB services continuing indefinitely at pre-lockdown levels. The horizontal dashed line in each figure indicates zero
overall change; the region above this line corresponds to a net increase in TB burden over the next 5 years, and vice versa. Overall, and in agreement with recent analysis[22], the
figure illustrates that TB transmission reductions are likely to lead to overall reductions in TB burden only when strong transmission reductions are combined with mild disruptions
(orange lines, at >50% transmission reductions for Kenya, and >75% transmission reductions for India and Ukraine).
L. Cilloni et al. / EClinicalMedicine 28 (2020) 100603 7Discussion
This modelling analysis in three key countries illustrates that even
short COVID-related lockdowns can generate long-lasting setbacks in
TB control. Our results suggest that, in a severe disruption scenario,
over the next five years TB deaths could see increases of 416%,
while TB incidence could see increases of 39%, in the three countries
studied here (Figs. 1 and 2, and Table 2). Our work also illustrates
some differences between country settings, in the potential impact of
lockdowns. For example, percentage increases in TB burden tend to
be higher in India than in Kenya and Ukraine (Table 2). On the one
hand, our estimates for the initial delay before first presentation for
care are substantially higher for Kenya than for India (respectively,
over a year and around 6 months respectively  see Tables S4 and
S5). If the majority of transmission has already occurred by the time a
symptomatic first presents for care, then service disruptions may
have only limited impact on TB burden; we expect the same to apply
in any high-prevalence setting, with prolonged pre-careseeking
delays. On the other hand, Ukraine is a setting with substantially
lower incidence than India or Kenya, and therefore weaker transmis-
sion: overall, we might expect lockdown-related increases in long-
term incidence and mortality to be exacerbated in settings with
higher levels of TB transmission, and vice-versa.
Our overall projections are broadly consistent with other, recent
modelling work that also aimed to assess the potential impact of
lockdown-related disruptions, on TB control [22,25]. However, our
work complements these analyses by paying specific attention to the
TB care cascade in different countries. While it is not possible to pre-
dict the trajectories of lockdowns, or associated disruptions in health
services in any country, our work instead aims to identify the specifictypes of disruptions that would be most influential for long-term TB
burden. These insights can be valuable in informing planning for
post-lockdown TB measures in any country setting beyond those that
we have examined here. In particular, Fig. 4 illustrates that the spe-
cific disruptions posing the greatest risk for long-term increases in TB
incidence and mortality are those that permit an expansion in the
pool of undetected, untreated TB: that is, disruptions hindering
access to care amongst TB symptomatics, as well as the availability of
diagnostic capacity when patients do access health faciities. Our anal-
ysis highlights how the expanded pool of undetected TB may con-
tinue to seed new infections of latent TB, many of which would take
years to manifest as incident TB disease. Consequently, service dis-
ruptions give rise to a short-term escalation of TB mortality (Fig. 2),
followed by a prolonged increase in incidence that could take years
to undo (Fig. 1).
It follows that the adverse, long-term impact of these disruptions
could be averted through focused efforts to address the problem of
undetected TB, immediately upon lifting restrictions. In Fig. 4 we
illustrate one scenario, where such supplementary measures aim to
reach a target of notifying 17 cases per 100,000 population, per
month. We have not aimed here to define how such targets might be
reached since optimal approaches are likely to vary across different
settings. For example, it is likely that such supplementary measures
would involve some form of active case-finding,[26,27] including
contact tracing with longitudinal follow-up [28]. At the same time, in
settings where careseeking rapidly restores to normal, it is possible
that the manifestation of ‘pent‑up demand’ could contribute substan-
tially towards this target. In this scenario, it is important for TB pro-
grammes to retain the capacity needed to meet this post-lockdown
surge in demand. In practice, a combination of both approaches may
8 L. Cilloni et al. / EClinicalMedicine 28 (2020) 100603be needed, even at a time when TB programmes are operating under
severe constraints in human and material resources. In the face of
these constraints, anticipating the need for these concentrated efforts
will be invaluable for planning, both by country programmes and by
international donors who could support these efforts.
On the patient side, COVID-19 and pulmonary TB are both associ-
ated with respiratory symptoms. If, during the current pandemic,
COVID-19 comes to be seen as a “TB-like” disease, public recognition
of the importance of recognising TB symptoms may wane once
COVID-19 is thought to be under control. Additional efforts may
therefore be needed to address these misperceptions. An additional
concern is that COVID-19 may carry stigma in many communities,
and this stigma may transfer to individuals with TB as well [29]. Con-
versely, there may be opportunities to leverage synergies between
the two diseases; for example, integrated TB and COVID-19 screening
and testing algorithms or combined contact investigation strategies.
Any such strategies based on respiratory symptoms could use similar
infrastructure and staff to mitigate both the direct impacts of SARS-
CoV-2 transmission and the indirect effects of augmented M. tubercu-
losis transmission. We emphasise that, readiness to restore TB serv-
ices as rapidly as possible, combined with focused efforts to ‘catch up’
on missed diagnoses, will be critical in limiting any long-term setback
to TB care efforts as a result of the COVID-19 response.
One important uncertainty is the potential impact of the lock-
down, on TB transmission. Assuming a 50% reduction in transmission,
our results suggest the possibility of a mild disruption to yield a net
reduction in 5-year incidence, in Kenya and Ukraine (Fig.1, and
Table 2). More broadly, our sensitivity analysis (Fig. 5) illustrates that
transmission reductions would only lead to a net decrease in TB bur-
den over the next five years if these reductions are relatively strong,
coupled with disruptions to TB services that are relatively mild. These
results are in agreement with recent modelling analysis, that simi-
larly showed how transmission reductions are unlikely to outweigh
the negative impacts of disruptions to TB services [22]. We caution
that  as with any models not fully capturing household and other
population structures - these simulations are likely to overestimate
the rate-of-change in TB incidence over short timescales, such as the
drop in TB incidence shown during the lockdown period. Nonethe-
less, these and similar results remain qualitatively illustrative of the
potential importance of changes in transmission.
A key implication of our scenario analysis is the centrality of
establishing surveillance and other data systems to inform the extent
of lockdown-associated disruptions in TB care. For example, TB notifi-
cations (e.g., ref [30]) can be monitored in real time at a national and
subnational level, to evaluate the depth and duration of any reduc-
tions in TB diagnosis at different stages of any lockdown. If these indi-
cators suggest persistent declines in notifications and/or falling levels
of treatment success, targeted interventions (e.g., active case finding,
treatment support, or expanded access) can be rapidly implemented.
As contact investigation for TB is implemented, surveillance of infec-
tion and active TB can be established and time trends can be used to
inform whether household transmission has increased and/or access
to care has declined, again at the local, subnational, and national lev-
els. In the longer term, community-based surveys (e.g., serial surveys
of TB infection in young children [31], can be conducted to explore
the impact of lockdowns on TB transmission more broadly.
We note that the present analysis does not address the potential
for direct interactions between TB and COVID-19 (for example,
increased risk of COVID-19 mortality amongst individuals with TB).
For this reason, our estimates for excess mortality in particular are
likely to be conservative. For example, early evidence suggests that
existing TB infection, whether latent or active, can be a strong risk
factor for severe disease resulting from SARS-CoV-2 infection[32],
although this association may vary by setting [33,34]. Moreover,
through pre-existing lung damage [35], past TB infection might also
predispose individuals to poorer outcomes from COVID-19. Furtherevidence on both potential impacts, particularly from longitudinal
cohorts) [36], would be invaluable for future work examining these
potential pathogen-pathogen interactions.
As with any modelling study, our analysis involves several simpli-
fications. Our models do not distinguish age structure, nor pulmonary
versus extrapulmonary TB, instead taking an average over these dis-
tinctions. For our modelling of Kenya, for simplicity we have only
captured the transmission dynamics of TB, treating HIV incidence as
pre-specified. Our model therefore does not capture the potential TB
implications of disruptions in HIV care, and for this reason may be
conservative. Lockdowns are likely to reduce community transmis-
sion but at the expense of intensifying and prolonging household and
congregate setting exposure. Faithfully capturing household contact
structure is generally not feasible in compartmental models such as
in the current analysis, and instead we have taken a simple approach
of an assumed overall net reduction in transmission. Finally, while
our work has concentrated on three country settings capturing key
challenges in the TB care cascade, future work should address other
settings (such as in South America), as well as the effect of disrup-
tions at the subnational level, if lockdowns against COVID-19 increas-
ingly become implemented at city- and provincial-levels.
In conclusion, our analysis illustrates how increases in TB burden
can take months to manifest, but years to undo. Even if a lockdown is
a period of curtailed programmatic activity, our results also highlight
how this period might be used by country programmes and interna-
tional agencies to prepare for the timely restoration of TB control
activities and even “catch-up” campaigns upon easing of restrictions,
to prevent such long-term negative impacts from taking hold. The
resilience of systems to end TB worldwide will depend critically on
readiness to restore, supplement and monitor TB services as rapidly
as possible.
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